Literature DB >> 22283464

Cochlear function in Ménière's disease.

Bela Büki1, Heinz Jünger, Paul Avan.   

Abstract

OBJECTIVE: The authors assessed the effectiveness of therapy, common features of pure-tone audiograms, and results of non-invasive electrocochleography before and after mild inhibition of peripheral vestibular function by infrequent administration of single intratympanic gentamicin injections (ITPG) in patients with Ménière's disease (MD). STUDY SAMPLE: Sixty-two patients with Ménière's disease.
DESIGN: Retrospective study.
RESULTS: Out of 62 patients 65% received one injection, 24% two, 6% three, 3% five, and 2% six injections. Between injections, class A vertigo control was obtained after two weeks in all cases. Before ITPG, out of 62 pure-tone threshold audiograms 37 were 'flat'. Average hearing threshold at 2 kHz was significantly better than that of 250, 500, and 0.75 kHz on the affected side.
CONCLUSIONS: Hearing threshold in advanced MD is often flat with a characteristic small peak in the high frequency range, most frequently around 2-3 kHz. Should the complaints be intolerable, single injection ITPG-therapy may be safe and effective.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22283464     DOI: 10.3109/14992027.2011.645508

Source DB:  PubMed          Journal:  Int J Audiol        ISSN: 1499-2027            Impact factor:   2.117


  2 in total

1.  Vitamin D supplementation may improve symptoms in Meniere's disease.

Authors:  Bela Büki; Heinz Jünger; Yunxia Wang Lundberg
Journal:  Med Hypotheses       Date:  2018-04-24       Impact factor: 1.538

Review 2.  The Price of Immune Responses and the Role of Vitamin D in the Inner Ear.

Authors:  Béla Büki; Heinz Jünger; Yan Zhang; Yunxia Wang Lundberg
Journal:  Otol Neurotol       Date:  2019-07       Impact factor: 2.311

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.